— Know what they know.
Not Investment Advice
Also trades as: ANN.AX (ASX) · $vol 15M · ANSLY (OTC) · $vol 0M

ANSLF OTC

Ansell Limited
1W: +0.0% 1M: +1.9% 3M: +10.5% YTD: +2.8% 1Y: +8.1% 3Y: +60.6% 5Y: -19.5%
$21.64
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 54 · $3.0B mcap · 142M float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$355M +48.3% ▲
5Y CAGR: +17.9%
Capital Expenditures
$50M +27.8% ▲
5Y CAGR: -9.7%
Free Cash Flow
$305M +79.3% ▲
5Y CAGR: +33.4%
Dividends Paid
$80M -26.3% ▼
Buybacks
$0 +100.0% ▲
Net Change in Cash
$10M +101.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$150M$146M$76M$0$213M
Depreciation & Amort.$62M$67M$74M$0$0
Stock-Based Comp.-$4M-$8M$6M$0$0
Change in Working Capital-$52M-$47M$90M-$48M$13M
Other Non-Cash Items$124M$184M$13M$288M$128M
Operating Cash Flow$192M$162M$259M$239M$355M
— Investing Activities —
Capital Expenditures-$64M-$66M-$63M-$69M-$50M
Acquisitions (Net)$1M-$11M$0-$635M-$11M
Investment Purchases-$5M-$99K$0-$200K$0
Investment Sales$0$0$0$0$0
Other Investing-$4M$3M-$600K$1M$0
Investing Cash Flow-$68M-$75M-$63M-$703M-$61M
— Financing Activities —
Net Debt Issuance-$17M-$39M$367M-$82M-$39M
Stock Repurchased-$48M-$8M-$30M-$4M$0
Dividends Paid-$83M-$62M-$53M-$64M-$80M
Other Financing-$132M-$40M-$48M-$66M-$29M
Financing Cash Flow-$149M-$131M$541M-$216M-$287M
Net Change in Cash-$14M-$40M$753M-$674M$10M
Cash End of Period$206M$159M$912M$238M$249M
Free Cash Flow$128M$95M$195M$170M$305M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms